A pharmacist-led follow-up program for patients with coronary heart disease in North Norway-a qualitative study exploring patient experiences

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Garcia, Beate Hennie ^a,b   Storli, Sissel Lisa ^b   Småbrekke, Lars ^b  

^a Hospital Pharmacy of North Norway Trust   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Clinical pharmacist; Coronary heart disease; Follow up program; Patient experience; Qualitative study

Indexed keywords

AGED; ATTITUDE TO HEALTH; CLINICAL TRIAL; COOPERATION; CORONARY DISEASE; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; NORWAY; PHARMACIST; PHYSICIAN; PROFESSIONAL STANDARD; PSYCHOLOGY; QUALITATIVE RESEARCH; UTILIZATION;

AGED; COOPERATIVE BEHAVIOR; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NORWAY; PATIENT DISCHARGE; PHARMACISTS; PHYSICIANS; PROFESSIONAL ROLE; QUALITATIVE RESEARCH;

EID: 84898746260     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-197     Document Type: Article

References (35)

1. Mackay J, Mensah G, Atlas of Heart Disease and Stroke Part III, Chapter 14 Deaths from Coronary Heart Disease 2004 [ http://www.who.int/entity/ cardiovascular-diseases/en/cvd-atlas-14-deathHD.pdf ] Accessed 2014-03-24
2. The challenge for preventive cardiology. Kotseva K, Wood D, Eur J Cardiovasc Prev Rehabil 2009 16 Suppl 2 19 S23 19675431
3. Treatment of patients with coronary heart disease fails to meet standards of european guidelines: results of EUROASPIRE surveys. Kotseva K, Rev Esp Cardiol 2009 62 10 1095 1098 10.1016/S0300-8932(09)72377-2 19793514
4. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. WooD DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, Holden A, De Bacquer D, Collier T, De Backer G, Faergeman O, Lancet 2008 371 9629 1999 2012 10.1016/S0140-6736(08)60868-5 18555911 (Pubitemid 351799857)
5. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting. Till LT, Voris JC, Horst JB, J Manag Care Pharm 2003 9 3 269 273 14613471
6. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. Hunt JS, Siemienczuk J, Pape G, Rozenfeld Y, MacKay J, LeBlanc BH, Touchette D, J Gen Intern Med 2008 23 12 1966 1972 10.1007/s11606-008-0791-x 18815843
7. An intervention to improve secondary prevention of coronary heart disease. Bailey TC, Noirot LA, Blickensderfer A, Rachmiel E, Schaiff R, Kessels A, Braverman A, Goldberg A, Waterman B, Dunagan WC, Arch Intern Med 2007 167 6 586 590 10.1001/archinte.167.6.586 17389290 (Pubitemid 46513228)
8. Intervention to improve adherence to ACC/AHA recommended adjunctive medications for the management of patients with an acute myocardial infarction. Axtell SS, Ludwig E, Lope-Candales P, Clin Cardiol 2001 24 2 114 118 10.1002/clc.4960240204 11214740 (Pubitemid 32108619)
9. Pharmacist interventions to improve the management of coronary artery disease. Chapman NR, Fotis MA, Yarnold PR, Gheorghiade M, Am J Health Syst Pharm 2004 61 24 2672 2678 15646702 (Pubitemid 40394651)
10. Adherence to clinical practice guidelines for 7 chronic conditions in long-term-care patients who received pharmacist disease management services versus traditional drug regimen review. Horning KK, Hoehns JD, Doucette WR, J Manag Care Pharm 2007 13 1 28 36 17269834 (Pubitemid 46824248)
11. The Framingham Risk Score. [ http://www.framinghamheartstudy.org/risk- functions/coronary-heart-disease/10-year-risk.php ]-Accessed 2014-03-24
12. Pharmacist-led cardiac risk reduction model. Taveira TH, Wu WC, Martin OJ, Schleinitz MD, Friedmann P, Sharma SC, Prev Cardiol 2006 9 4 202 208 10.1111/j.1520-037X.2006.05339.x 17085982
13. The clinical and economic impact of a secondary heart disease prevention clinic jointly implemented by a practice nurse and pharmacist. Reilly V, Cavanagh M, Pharm World Sci 2003 25 6 294 298 14689819 (Pubitemid 37498936)
14. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. Lee JK, Grace KA, Taylor AJ, JAMA 2006 296 21 2563 2571 10.1001/jama.296.21.joc60162 17101639 (Pubitemid 44903860)
15. Physician-pharmacist collaborative care in dyslipidemia management: the perception of clinicians and patients. Lalonde L, Hudon E, Goudreau J, Belanger D, Villeneuve J, Perreault S, Blais L, Lamarre D, Res Social Adm Pharm 2011 7 3 233 245 10.1016/j.sapharm.2010.05.003 21272548
16. Patients' perspectives of a multifaceted intervention with a focus on technology: a qualitative analysis. Lambert-Kerzner A, Havranek EP, Plomondon ME, Albright K, Moore A, Gryniewicz K, Magid D, Ho PM, Circ Cardiovasc Qual Outcomes 2010 3 6 668 674 10.1161/CIRCOUTCOMES.110.949800 20923992
17. Collaborative prescribing: A qualitative exploration of a role for pharmacists in mental health. Wheeler A, Crump K, Lee M, Li L, Patel A, Yang R, Zhao J, Jensen M, Res Social Adm Pharm 2012 8 3 179 92 10.1016/j.sapharm.2011. 04.003 21831724
18. Factors affecting adherence to antihypertensive medication in Greece: results from a qualitative study. Tsiantou V, Pantzou P, Pavi E, Koulierakis G, Kyriopoulos J, Patient Prefer Adherence 2010 4 335 343 20859460
19. Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study. Bereznicki B, Peterson G, Jackson S, Haydn WE, DeBoos I, Hintz P, J Clin Pharm Ther 2011 36 3 348 355 10.1111/j.1365-2710.2010. 01187.x 21545614
20. Acceptability of community pharmaceutical care in Portugal: a qualitative study. Guerreiro M, Cantrill J, Martins P, J Health Serv Res Pol 2010 15 4 215 222 10.1258/jhsrp.2010.009121
21. Farmasøytisk oppfølging av pasienter med hjertesykdom: en kvalitativ studie av pasientenes erfaringer. Mahmoud HF, Eng: Pharmaceutical follow-up of patients with coronary heart disease: a qualitative study of patient experiences University of Tromsoe, Department of Pharmacy Masters thesis. 2010 [ http://munin.uit.no/handle/10037/2754 ] Accessed 2014-03-24
22. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Graneheim UH, Lundman B, Nurse Educ Today 2004 24 2 105 112 10.1016/j.nedt.2003.10.001 14769454 (Pubitemid 38232767)
23. Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects. The World Medical Association, 2008 Report. [ http://wma.net/en/30publications/10policies/b3/ ] Accessed 2014-03-24
24. Concordance, adherence and compliance in medicine taking: report for the National Co-ordinating Centre for NHS Sercive Delivery and Organisation R&D (NCCSDO). Horne R, Weinman J, Barber N, Elliot R, 2005 Report. [ http://www.academia.edu/855004/Concordance-Adherence-and-Compliance-in-Medicine- Taking ]
25. Compliance, concordance, adherence. Aronson JK, Br J Clin Pharmacol 2007 63 4 383 384 10.1111/j.1365-2125.2007.02893.x 17378797 (Pubitemid 46426642)
26. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, Cowper PA, Landsman PB, Cohen HJ, Feussner JR, Am J Med 1996 100 4 428 437 10.1016/S0002-9343(97)89519-8 8610730 (Pubitemid 26115198)
27. The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience. Strand LM, Cipolle RJ, Morley PC, Frakes MJ, Curr Pharm Des 2004 10 31 3987 4001 10.2174/1381612043382576 15579084 (Pubitemid 39591913)
28. Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs). Viktil KK, Blix HS, Moger TA, Reikvam A, Pharmacoepidemiol Drug Saf 2006 15 9 667 674 10.1002/pds.1238 16598835 (Pubitemid 44404666)
29. Opportunities and responsibilities in pharmaceutical care. Hepler CD, Strand LM, Am J Hosp Pharm 1990 47 3 533 543 2316538 (Pubitemid 20138134)
30. Effect of Medication Nonadherence on Hospitalization and Mortality Among Patients With Diabetes Mellitus. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ, Arch Intern Med 2006 166 17 1836 1841 10.1001/archinte.166.17.1836 17000939 (Pubitemid 44455165)
31. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. Barnett MJ, Frank J, Wehring H, Newland B, VonMuenster S, Kumbera P, Halterman T, Perry PJ, J Manag Care Pharm 2009 15 1 18 31
32. LOV 2000-06-02 nr 39: Lov om apotek (apotekloven) [Eng: Norwegian Law concerning Pharmacies of June 2, 2000] Statute [ http://lovdata.no/dokument/NL/ lov/2000-06-02-39 ] Accessed 2014-03-24
33. Dahlberg K, Dahlberg H, Nystrøm M, An open lifeworld approach Lund: Studentlitteratur 2 Reflective Lifeworld Research. 2008 95 121
34. Evaluation of qualitative research. Horsburgh D, J Clin Nurs 2003 12 2 307 312 10.1046/j.1365-2702.2003.00683.x 12603565 (Pubitemid 37243893)
35. Establishing the credibility of qualitative research findings: the plot thickens. Cutcliffe JR, McKenna HP, J Adv Nurs 1999 30 2 374 380 10.1046/j.1365-2648.1999.01090.x 10457239